ADDED
As of March 27, 2026, there were 55,034,047 shares of the registrant s Class A common stock outstanding.
( Marvel ), Solana Company (Hong Kong) Limited ( SCHK ), Helius Medical, Inc.
FORWARD-LOOKING STATEMENTS This Form 10-K includes forward-looking statements that involve risks and uncertainties, including statements regarding the Company s market, strategy, competition, capital needs, business plans and expectations.
In some cases, you can identify forward-looking statements by terminology such as may, will, should, expect, plan, intend, anticipate, believe, estimate, predict, potential, continue, or the negative of such terms or other comparable terminology.
Food and Drug Administration ( FDA ), filings and their subsequent approvals, other foreign or domestic regulatory filings; the safety and effectiveness of our product; our market awareness; our ability to compete effectively; the ability and limitation of our manufacturing sources; our distribution network; the adequacy of our intellectual property protection; our future patent approvals; our future expenses and cash flow; our ability to become profitable; our future financing arrangements; and any future stock price.
These forward-looking statements speak only as of the date of this Form 10-K.
SUMMARY RISK FACTORS Our business is subject to a number of risks, as fully described in Item 1A.
BUSINESS Overview We are a listed digital asset treasury ( DAT ) dedicated to acquiring and holding Solana tokens ( SOL ).
Solana Company s DAT objective is to maximize SOL per share through strategic use of capital markets and onchain opportunities, offering public market investors direct exposure to Solana.
Strategic digital asset reserves like SOL lay the groundwork for a future where global payments, credentialing, and personalized learning can be powered by decentralized infrastructure, enhancing how we grow our company.
REMOVED
As of March 18, 2025, there were 6,126,778 shares of the registrant s Class A common stock outstanding.
All statements contained herein that are not clearly historical in nature are forward-looking and the words anticipate, believe, calls for, could depends, estimate, expect, extrapolate, foresee, goal, intend, likely, might, plan, project, propose, potential, target, think, and similar expressions, or that events or conditions may, should occur will, would, or any similar expressions are generally intended to identify forward-looking statements.
The forward-looking statements in this Form 10-K include but are not limited to statements relating to: the Company s future growth and operational progress, including manufacturing activities for the PoNS device, receipt of prescriptions and progress of commercialization of the PoNS device in the U.S., our ability to receive adequate reimbursement coverage under Medicare, Medicaid or under other insurance plans, clinical development plans, product development activities, plans for U.S.
Such forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by Helius, are inherently subject to significant business, economic, competitive political and social uncertainties and contingencies.
Except as required by law, we assume no obligation to update or revise these forward-looking statements for any reason, even if new information becomes available in the future.
for other indications and may never obtain such authorizations and/or certifications; Generation of revenue related to the PoNS technology is dependent on the PoNS Therapy being prescribed by physicians in the U.S.
INDUSTRY AND MARKET DATA In this Form 10-K, we reference information, statistics and estimates regarding the medical devices and healthcare industries.
We have obtained this information from various third-party sources, including industry and general publications, reports by market research firms and other sources.
This information involves a number of assumptions and limitations, and we have not independently verified the accuracy or completeness of this information.
Some data and other information are also based on the good faith estimates of management, which are derived from our research, review of internal surveys, general information discussed in the industry, and third-party sources.